Large-scale testing (Phase 3)Looking for participantsNCT05512364
What this trial is testing
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
Who this might be right for
ER-positive Breast CancerHER2-negative Breast CancerStage IIB Breast Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC 220